GSE185872 methotrexate macrophage 0 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE185872_methotrexate_macrophage_0_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE185872_methotrexate_macrophage_0_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE185872_methotrexate_macrophage_0_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE185872_methotrexate_macrophage_0_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

HAS2 antisense RNA 1

Gene

TPTEP2-CSNK1E readthrough

Gene

long intergenic non-protein coding RNA 1303

Gene

STARD13 antisense RNA

Gene

PDCD6IP pseudogene 1

Gene

Y-box binding protein 1 pseudogene 4

Gene

nucleophosmin 1 pseudogene 23

Gene

EBAG9 pseudogene 1

Gene

immunoglobulin heavy constant epsilon P2 (pseudogene)

Gene

uncharacterized LOC100132078

  • Gene

    HAS2 antisense RNA 1


  • Gene

    TPTEP2-CSNK1E readthrough


  • Gene

    long intergenic non-protein coding RNA 1303


  • Gene

    STARD13 antisense RNA


  • Gene

    PDCD6IP pseudogene 1


  • Gene

    Y-box binding protein 1 pseudogene 4


  • Gene

    nucleophosmin 1 pseudogene 23


  • Gene

    EBAG9 pseudogene 1


  • Gene

    immunoglobulin heavy constant epsilon P2 (pseudogene)


  • Gene

    uncharacterized LOC100132078

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.